✦ LIBER ✦

Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

✍ Scribed by Alexey A. Mazaev; Yaroslav A. Naimushin; Valery P. Masenko; Mikhail Y. Ruda; Alexey V. Mazurov

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 205 KB
Volume: 27
Category: Article
ISSN: 0929-5305
DOI: 10.1007/s11239-007-0183-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Pharmacodynamic Evaluation o

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

✍ Jorge F. Saucedo; Henry K. Lui; Luis Garza; G. Jose Guerra; Mary V. Jacoski; Lis 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 179 KB

Utilization of catheterization and revas

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

✍ Glenn N. Levine; A. Michael Lincoff; James J. Ferguson III; Kenneth W. Mahaffey; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

Balancing the benefits and risks of anti

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention

✍ Jorge F. Saucedo 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 349 KB

A prospective cohort study of prognostic

A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes

✍ Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Kathrin Niemöller; Albert Schömi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 257 KB

Efficacy and safety of optimized antithr

Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice

✍ Tobias Heer; Claus Juenger; Anselm K. Gitt; Timm Bauer; Frank Towae; Ralf Zahn; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 243 KB

Influence of abciximab on evolution of l

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

✍ Stefanie Schulz; Julinda Mehilli; Gjin Ndrepepa; Franz Dotzer; Michael Dommasch; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 257 KB